What you need: age, sex, smoking status, blood pressure, and an LDL/HDL panel β ApoB and Lp(a) are optional extras.
Advanced Lipid & Cardiovascular Risk Calculator
How to use this calculator
Enter your age, sex, smoking status, blood pressure, and an LDL/HDL panel. Add ApoB and Lp(a) if your last panel included them β both are optional.
What your result means
This counts major risk factors rather than a validated 10-year percentage β SCORE2 (Europe) and the ASCVD Pooled Cohort Equations (US) are calibrated regression tools, and reproducing them without that calibration risks a falsely precise number. ApoB is increasingly considered a more direct measure of atherogenic particle burden than LDL-C alone; Lp(a) is largely genetically determined and usually only needs testing once in a lifetime. Use this as a directional factor count, and get an actual percentage and personalized guidance from a doctor.
aweGene provides general wellness information for educational purposes only β it is not medical advice, diagnosis, or treatment. Always consult a licensed physician before making health decisions.
Questions and answers
Why include ApoB and Lp(a)?
ApoB reflects the number of cholesterol-carrying particles that can build up in arteries, and Lp(a) is largely inherited. Both add information beyond a standard cholesterol panel.
Is the result a percentage risk?
No. Like the other aweGene cardiovascular tool, it highlights risk factors to discuss with your doctor rather than predicting a percentage.
aweGene tools are educational estimates and do not replace professional medical advice.
Sources and background reading
The methods and ideas behind this tool. aweGene calculators are educational estimates, not clinical implementations. Links open PubMed or the publisher.
Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol 2019;4(12):1287-1295. Open →
Tsimikas S. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol 2017;69(6):692-711. Open →
